Marketing-authorisation holder · Canada
Auro Pharma Inc
467 medicines in 1 country, as authorisation holder.
Group structure
Part of
AUROPharmaceutical groupOther companies in the group
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 467
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETYLCYSTEINE INJECTION200 mg / ml · Solution | Acetylcysteine | Canada | Authorised | |
| ACYCLOVIR SODIUM INJECTION50 mg / ml · Solution | Aciclovir | Canada | Marketed | 2020 |
| AMPICILLIN SODIUM FOR INJECTION BP1 g / vial · Powder For Solution | Ampicillin | Canada | Marketed | 2017 |
| AMPICILLIN SODIUM FOR INJECTION BP250 mg / vial · Powder For Solution | Ampicillin | Canada | Marketed | 2017 |
| AMPICILLIN SODIUM FOR INJECTION BP500 mg / vial · Powder For Solution | Ampicillin | Canada | Marketed | 2017 |
| AMPICILLIN SODIUM FOR INJECTION BP2 g / vial · Powder For Solution | Ampicillin | Canada | Marketed | 2017 |
| ARSENIC TRIOXIDE FOR INJECTION2 mg / ml · Solution | Arsenicum album | Canada | Authorised | |
| AURO-ABACAVIR/LAMIVUDINE600 mg + 300 mg · Tablet | Abacavir, Lamivudine | Canada | Marketed | 2016 |
| AURO-ALENDRONATE10 mg · Tablet | Alendronic acid | Canada | Marketed | 2012 |
| AURO-ALENDRONATE70 mg · Tablet | Alendronic acid | Canada | Marketed | 2012 |
| AURO-ALFUZOSIN10 mg · Tablet (Extended-Release) | Alfuzosin | Canada | Marketed | 2015 |
| AURO-AMBRISENTAN10 mg · Tablet | Ambrisentan | Canada | Authorised | |
| AURO-AMBRISENTAN5 mg · Tablet | Ambrisentan | Canada | Authorised | |
| AURO-AMLODIPINE5 mg · Tablet | Amlodipine | Canada | Marketed | 2013 |
| AURO-AMLODIPINE10 mg · Tablet | Amlodipine | Canada | Marketed | 2013 |
| AURO-AMOXICILLIN250 mg / 5 ml · Powder For Suspension | Amoxicillin | Canada | Marketed | 2021 |
| AURO-AMOXICILLIN250 mg · Capsule | Amoxicillin | Canada | Marketed | 2012 |
| AURO-AMOXICILLIN125 mg / 5 ml · Powder For Suspension | Amoxicillin | Canada | Marketed | 2021 |
| AURO-AMOXICILLIN500 mg · Capsule | Amoxicillin | Canada | Marketed | 2012 |
| AURO-AMOXICLAV500 mg + 125 mg · Tablet | Amoxicillin, Clavulanic acid | Canada | Marketed | 2022 |
| AURO-AMOXICLAV250 mg + 125 mg · Tablet | Amoxicillin, Clavulanic acid | Canada | Marketed | 2022 |
| AURO-AMOXICLAV875 mg + 125 mg · Tablet | Amoxicillin, Clavulanic acid | Canada | Marketed | 2022 |
| AURO-APIXABAN5 mg · Tablet | Apixaban | Canada | Marketed | 2022 |
| AURO-APIXABAN2.5 mg · Tablet | Apixaban | Canada | Marketed | 2022 |
| AURO-APREMILAST10 mg + 20 mg + 30 mg · Tablet | Apremilast | Canada | Authorised |